12:00 AM
 | 
Jan 05, 2009
 |  BC Week In Review  |  Company News  |  Deals

Axordia, Intercytex Group plc deal

Intercytex acquired Axordia for 7 million shares, valuing the stem cell company at £1.7 million ($2.5 million) based on Intercytex's close of 24p on...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >